The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study

International Journal of Hyperthermia

Volumn 27, Issue 1, 2011, Pages 27-32

  Shen, Hua ^a   Li, Xiao Dong ^a,b   Wu, Chang Ping ^b   Yin, Yong Mei ^a   Wang, Rong Sheng ^a   Shu, Yong Qian ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

chemotherapy; Gemcitabine; hyperthermia; non small cell lung cancer; quality of life

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; ARTICLE; BONE MARROW DEPRESSION; CANCER GROWTH; CANCER REGRESSION; CHEMOTHERAPY INDUCED EMESIS; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DYSPNEA; FEMALE; HUMAN; HYPERTHERMIC THERAPY; KIDNEY FUNCTION; LIVER FUNCTION; LUNG NON SMALL CELL CANCER; MACULE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPHIL; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; RADIOFREQUENCY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN DISEASE; THROMBOCYTE; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; RADIO WAVES; REMISSION INDUCTION;

EID: 79251485033     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2010.500645     Document Type: Article

References (29)

1. Vertrees RA, Das GC, Popov VL, Coscio AM, Goodwin TJ, Logrono R, Zwischenberger JB, Boor PJ. Synergistic Interaction of Hyperthermia and Gemcitabine. Cancer Biol Ther 2005;4:1144-1153.
2. Pereira S, Fernandes PA, Ramos MJ. Mechanism for ribonu-cleotide reductase inactivation by the anticancer drug gemci-tabine. J Comput Chem 2004;25:1286-1294.
3. Rosell R, Danenberg KD, Alberola V, Bepler G, Sanchez JJ, Camps C, Provencio M, Isla D, Taron M, Diz P, Artal A. Spanish Lung Cancer Group. Ribonucleotide reductase mes-senger RNA expression and survival in gemcitabine/cisplatin-treated advanced nonsmall cell lung cancer patients. Clin Cancer Res 2004;10:1318-1325.
4. Pace E, Melis M, Siena L, Bucchieri F, Vignola AM, Profita M, Gjomarkaj M, Bonsignore G Effects of gemcitabine on cell proliferation and apoptosis in nonsmall-cell lung cancer (NSCLC) cell lines. Cancer Chemother Pharmacol 2000;46:467-476.
5. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247. doi: 10.1016/j.ejca.2008.10.026.
6. Kaba H, Fukuda H, Yamamoto S, Ohashi Y. Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0. Gan To Kagaku Ryoho. 2004 Aug;31(8):1187-1192.
7. Van der Zee J. Heating the patient A promising approach? Ann Oncol 2002;13:1173-1184.
8. Mohamed F, Marchettini P, Stuart OA, Urano M, Sugarbaker PH. Thermal enhancement of new chemothera-peutic agents at moderate hyperthermia. Ann Surg Oncol 2003;10:463-468.
9. Nagle VLJ, Berry JM, Bull JM. Whole body hyperthermia with carboplatin (CBDCA) for treatment of advanced or metastatic GI adenocarcinomas. Proc Am Assoc CA Res 1999;40:345.
10. Karino T, Koga S, Maeta M. Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors. Jpn J Surg 1988;18:276-283.
11. Song CW. Effect of local hyperthermia on blood flow and micro-environment. Cancer Res 1984;44:4721-4730.
12. Engin K. Biological rationale and clinical experience with hyperthermia. Control Clin Trials 1996;17:316-342.
13. Feyerabend T. Rationale and clinical status of local hyper-thermia, radiation and chemotherapy in locally advanced malignancies. Anticancer Res 1997;17:2895-2897.
14. Issels R. Hyperthermia combined with chemotherapy: Biological rationale, clinical application and treatment results. Oncology 1999;22:374-381.
15. Matthew CB. Hyperthermia-induced changes in the vascular permeability of rats: A model system to examine therapeutic interventions. JThermal Biol 2000;25:381-386.
16. Massing U. Cancer therapy with liposomal formations of anti-cancer drugs. Int J Clin Pharm Ther 1997;35:87-90.
17. Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, Papahadjopoulos D. Liposomes and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994;54:2186-2191.
18. Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999;15:345-370.
19. Maruyama K, Unezaki S, Takahashi N, Iwatsuru M. Enhanced delivery of doxorubicin to tumor by long-circulat-ing thermosensitive liposomes and local hyperthermia. Biochim Biophys Acta 1993;1149:209-216.
20. Unezaki S, Maruyama K, Takahashi N, Koyama M, Yuda T, Suginaka A, Iwatsuru M. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. Pharm Res 1994;11: 1180-1185.
21. Fujiwara K, Watanabe T. Effects of hyperthermia radiother-apy and thermoradiotherapy on tumor microvascular perme-ability. Acta Pathol Jpn 1990;40:79-84.
22. Gaber MH, Wu NZ, Hong K, Huang SK, Dewhirst MW, Papahadjopoulos D. Thermosensitive liposomes: Extravasation and release of contents in tumor microvascu-lar networks. Int J Radiat Oncol Biol Phys 1996;36: 1177-1187.
23. Hauck ML, Coffin DO, Dodge RK, Dewhirst MW, Mitchell JB, Zalutsky MR. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumor interstitial fluid pressure. Int J Hyperthermia 1997;13:307-316.
24. Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001;61:3027-3032.
25. Lefor A, Makohon S, Ackerman N. The effects of hyperther-mia on vascular permeability in experimental liver metastasis. J Surg Oncol 1985;28:297-300.
26. Dudar T, Jain R. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984;44: 605-612.
27. Eddy HA. Alterations in tumor microvasculature during hyperthermia. Radiology 1980;137:515-521.
28. Moriyama E. Cerebral blood flow changes during localized hyperthermia. Neurol Med Chir 1990;30:923-929.
29. Nishimura Y, Hiraoka M, Jo S, Akuta K, Yukawa Y, Shibamoto Y, Takahashi M, Abe M. Microangiographic and histologic analysis of the effects of hyperthermia on murine tumor microvasculature. Int J Radiat Oncol Biol Phys 1988;15:411-420.